Immutep achieves FDA Fast Track designation for soluble LAG-3 protein
April 12, 2021Sales and Marketing FDA, HNSCC
Immutep, a biotechnology company developing novel immunotherapy treatments for cancer, infectious disease, and autoimmune disease, has achieved FDA Fast Track …
Gynaecologic cancer research collaboration announced
April 12, 2021Sales and Marketing clinical oncology
Context Therapeutics and Integral Molecular have announced a research collaboration and licensing agreement for the development of an anti-claudin 6 …
Immunotherapy combination presented at AACR meeting shows promise in brain cancers
April 12, 2021Sales and Marketing Cancer Conferences | Cancer Conferences 2020 | Oncology Conferences | Oncology Conferences 2020 | International Cancer Conference
Researchers at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust have found that immunotherapy together with …
Pharmafile.com’s top 10 news stories of the week
April 9, 2021Medical Communications covid 19 news, covid-19 news, news, news roundup, pharma, pharma news
A number of new COVID-19 developments have emerged in April already: AstraZeneca has halted the trial of its COVID-19 vaccine …
Exscientia enter first-ever AI cancer drug into Phase I trials
April 9, 2021Medical Communications AI, Evotec, Exscientia, cancer treatment, oncology, pharma, pharma news
Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first …
Moderna publishes antibody persistence data of COVID-19 vaccine
April 9, 2021Medical Communications
Moderna have published antibody persistence data out to six months following the second dose of its COVID-19 vaccine (mRNA-1273) in …
Lily and Incyte Phase III COVID-19 study fails to meet primary endpoint
April 9, 2021Medical Communications COVID-19, Eli Lily
Results from Eli Lily and Incyte’s Phase III study, COV-BARRIER, evaluating baricitinib in the treatment of hospitalised COVID-19 patients did …
Abbott receives CE mark approval for TriClip device
April 9, 2021Medical Communications
Abbott have received CE Mark approval for its next-generation TriClip Transcatheter Tricuspid Valve Repair System, the first-of-its-kind tricuspid heart valve …
Novartis MS therapy gains MHRA and EC approval
April 8, 2021European Commission, MHRA, Novartis, pharma, pharma news
The MHRA and European Commission have both granted marketing authorisation to Novartis for its Kesimpta therapy, for the treatment of …
FDA approve Gilead’s breast cancer treatment after Phase III trial
April 8, 2021FDA, Gilead, Trodelvy, pharma, pharma news
The FDA has approved Gilead’s Trodelvy therapy for the treatment of metastatic triple-negative breast cancer (TNBC).
MHRA recommends AstraZeneca jab not be offered to under 30s
April 8, 2021The MHRA have recommended that people under the age of 30 not be offered the AstraZeneca COVID-19 vaccine, due to …
GBT publish successful results from sickle cell disease study
April 8, 2021Global Blood Therapeutics (GBT) have published the successful results from their Phase III study of Oxbryta (voxelotor) tablets in patients …
Collaboration announced to investigate COVID brain fog treatment
April 8, 2021Akili Interactive has announced a collaboration with Weill Cornell Medicine, New York-Presbyterian Hospital and Vanderbilt University Medical Center, to evaluate …
Intravac appoints Nathalie Laarakker as CFO
April 7, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Intravac have announced the appointment of Nathalie Laarakker as its new CFO and member of the company’s executive management team. …
Smithers promotes Nikki Lucas to Principal Project Manager
April 7, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Nikki Lucas has been appointed Principal Project Manager within Smithers’ Medical Device Physical Testing team. Lucas has over a decade …
New CEO appointed at Nordic Nanovector
April 7, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Nordic Nanovector have appointed Peter Braun as their new Chief Executive Officer. Braun is an experienced and entrepreneurial pharmaceutical leader, …
Ceryx Medical announce new chairman Chas Taylor
April 7, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Cardiovascular technology company Ceryx Medical have appointed Chas Taylor as their new chairman. The appointment comes at an interesting time …
Pharmafile.com’s weekly COVID-19 news round-up
April 7, 2021Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news
The past week has seen plenty of COVID-19 vaccine news; AstraZeneca has halted the paediatric trial of their jab amid …
UK begins rollout of Moderna COVID-19 vaccine
April 7, 2021Research and Development COVID-19, COVID-19 vaccine, Moderna, Moderna vaccine, pharma, pharma news
The first Moderna COVID-19 vaccine in the UK has today been administered, beginning the rollout of the country’s third vaccine …
Novartis and Artios Pharma to collaborate on DDR cancer therapies
April 7, 2021Research and Development Novartis, RLT, oncology
Novartis and Artios Pharma have announced a global research collaboration to discover and validate next generation DNA damage response (DDR) …
